Providing clients with a flexible approach to improve cycle times, constrain costs and reduce risks. Specialising in the planning, management, execution, and analysis of Phase II-III clinical trials.
Risk based, patient focused methodology for the design and execution of adaptive monitoring.
Our professionals apply their therapeutic, regulatory and operational expertise to consistently solve the challenges that arise during clinical projects.
Pressures such as stricter regulations, changing technologies and globalisation are stressing current operational models and information infrastructure to the limits. As these pressures intensify, applying the right methodology to anticipate the challenges that arise during the course of clinical trials is the only way to increase project success.
Innovative clinical trial designs that take advantage of our in depth statistical expertise.
Fast delivery of high quality and meaningful data means that you can make well informed decisions earlier in the trial. This also ensures patient protection and reliable trial results.
Endpoint Adjudication can help to lower the risk of variation in important clinical trial outcome events for submission to regulatory agencies.
Interactive Response Technology systems can effectively solve trial challenges including patient enrolment, randomisation, and dosing.
Timely and accurate Investigator payments are critical for keeping sites motivated and driving site performance in a study.
Experienced physicians and clinical research professionals support the planning, conduct, and evaluation of clinical trials.
Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.
300+ global pharmacovigilance experts bring together all safety services into a seamless delivery solution.
Sound regulatory strategies critically important in the ever evolving regulatory environment of clinical trials.
We are raising the bar in clinical excellence. By focusing on metrics that matter we are already delivering economic value to our clients. Our experience ranges from small studies to large, complex, multinational projects.
Keeping your clinical trial on track in an evolving environment.
ICON has adapted its services to support sponsors during this time; offering remote monitoring where on-site visits were not permitted, providing additional support to get IMP to patients and pre-recording investigator meetings because of travel restrictions.
ICON is proud to be supporting clients and government organisations in the search for a treatment or vaccine for COVID-19. Download our whitepaper on Pandemic respiratory vaccine clinical trials.